Alzheimer’s imaging pact

Drug-diagnostic giant Bayer Schering licenses an Alzheimer's-detecting positron emission tomography agent from Philadelphia molecular imaging firm Avid Radiopharmaceuticals. The deal, announced June 19, results from a 2005 option agreement between the two companies for AV1/ZK and related fluorine-based compounds, which target amyloid plaques in the brain...